Log in
Enquire now

List of Joslin Diabetes Center (company) patents

List of Joslin Diabetes Center (company) patents
List of Voxeljet patents
List of IPass (company) patents
List of CropDesign patents
List of funding rounds for Nubank
Companies in the Decentralized clinical trial industry
Patents where
Current Assignee
Name
is
Joslin Diabetes Center (company)Joslin Diabetes Center (company)
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11519008 Exosome delivery system

Patent 11519008 was granted and assigned to Joslin Diabetes Center (company) on December, 2022 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11519008
December 6, 2022
‌
US Patent 11433042 Methods and compositions for treating metabolic disorders

Patent 11433042 was granted and assigned to Joslin Diabetes Center (company) on September, 2022 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11433042
September 6, 2022
‌
US Patent 7338167 Retinal imaging system

Patent 7338167 was granted and assigned to Joslin Diabetes Center (company) on March, 2008 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7338167
March 4, 2008
‌
US Patent 7524492 Insulin related transcription factor and uses thereof

Patent 7524492 was granted and assigned to Joslin Diabetes Center (company) on April, 2009 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7524492
April 28, 2009
‌
US Patent 9791452 Methods of diagnosing and predicting renal disease

Patent 9791452 was granted and assigned to Joslin Diabetes Center (company) on October, 2017 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9791452
October 17, 2017
‌
US Patent 9921221 Predicting and treating diabetic complications

Patent 9921221 was granted and assigned to Joslin Diabetes Center (company) on March, 2018 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9921221
March 20, 2018
‌
US Patent 10488420 Methods of diagnosing and predicting renal disease

Patent 10488420 was granted and assigned to Joslin Diabetes Center (company) on November, 2019 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10488420
November 26, 2019
‌
US Patent 9763998 Serpins: methods of therapeutic β-cell regeneration and function

Patent 9763998 was granted and assigned to Joslin Diabetes Center (company) on September, 2017 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9763998
September 19, 2017
‌
US Patent 7256176 Methods of modulating β cell function

Patent 7256176 was granted and assigned to Joslin Diabetes Center (company) on August, 2007 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7256176
August 14, 2007
‌
US Patent 9446096 Glypican-4 based compositions and methods for treating and diagnosing insulin resistance

Patent 9446096 was granted and assigned to Joslin Diabetes Center (company) on September, 2016 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9446096
September 20, 2016
‌
US Patent 9283262 Predicting and treating diabetic complications

Patent 9283262 was granted and assigned to Joslin Diabetes Center (company) on March, 2016 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9283262
March 15, 2016
‌
US Patent 9976140 Microrna and uses in brown fat differentiation

Patent 9976140 was granted and assigned to Joslin Diabetes Center (company) on May, 2018 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9976140
May 22, 2018
‌
US Patent 11078259 Methods and compositions for promoting thermogenic potential

Patent 11078259 was granted and assigned to Joslin Diabetes Center (company) on August, 2021 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11078259
August 3, 2021
‌
US Patent 9346869 Methods and compositions for inducing brown adipogenesis

Patent 9346869 was granted and assigned to Joslin Diabetes Center (company) on May, 2016 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9346869
May 24, 2016
‌
US Patent 7700555 Methods of treating diabetes

Patent 7700555 was granted and assigned to Joslin Diabetes Center (company) on April, 2010 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7700555
April 20, 2010
‌
US Patent 8080374 Methods of diagnosing cardiovascular disease

Patent 8080374 was granted and assigned to Joslin Diabetes Center (company) on December, 2011 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8080374
December 20, 2011
‌
US Patent 7695961 Insulin related transcription factor and uses thereof

Patent 7695961 was granted and assigned to Joslin Diabetes Center (company) on April, 2010 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7695961
April 13, 2010
‌
US Patent 8372582 Methods of modulating metabolic memory

Patent 8372582 was granted and assigned to Joslin Diabetes Center (company) on February, 2013 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8372582
February 12, 2013
‌
US Patent 8343939 Methods of modulating angiogenesis

Patent 8343939 was granted and assigned to Joslin Diabetes Center (company) on January, 2013 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8343939
January 1, 2013
‌
US Patent 8445467 Reducing risk of type 2 diabetes (T2D)

Patent 8445467 was granted and assigned to Joslin Diabetes Center (company) on May, 2013 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8445467
May 21, 2013
‌
US Patent 8652488 Insulin B chain autoantigen composition

Patent 8652488 was granted and assigned to Joslin Diabetes Center (company) on February, 2014 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8652488
February 18, 2014
‌
US Patent 7101845 Methods of modulating β cell function

Patent 7101845 was granted and assigned to Joslin Diabetes Center (company) on September, 2006 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7101845
September 5, 2006
‌
US Patent 10632175 Exercise-regulated adipokines as therapy for diabetes management

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10632175
April 28, 2020
‌
US Patent 9328331 Compositions and methods for promoting beta cell maturity

Patent 9328331 was granted and assigned to Joslin Diabetes Center (company) on May, 2016 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9328331
May 3, 2016
‌
US Patent 7175844 Methods of modulating fibrosis

Patent 7175844 was granted and assigned to Joslin Diabetes Center (company) on February, 2007 by the United States Patent and Trademark Office.

Joslin Diabetes Center (company)
Joslin Diabetes Center (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
7175844
February 13, 2007
Results per page:
36 results
0 selected
36 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us